CClinicalTrials.gg
CompletedNCT03015142Updated Mar 8, 2022Results posted

Observational Clinical Study to Plan, Position and Check Instrument Placement for Spine Surgery Interventions

An observational study in Spinal Diseases, sponsored by Philips Clinical & Medical Affairs Global. Completed at 1 site in Sweden. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2022-03-08.

Sponsored by Philips Clinical & Medical Affairs Global · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
21
Ages
16 Years and older
Sex
All
01

Study summary

There is a clear need in spine surgery to place pedicle screws in the right place in the spine with good accuracy to avoid damage to important structures (spinal cord, nerve roots or vertebral arteries). The objective of the study was to investigate the accuracy of screw placement during spine surgery.

02

Conditions studied

  • Spinal Diseases

Browse trials for

03

In context

Spinal Diseases

267 studies on the registry are indexed under Spinal Diseases; 54 are open to participants now.

This study's enrollment of 21 is below the median of 108 across 87 observational studies indexed under Spinal Diseases.

Browse Spinal Diseases studies →

Lead sponsor

Philips Clinical & Medical Affairs Global is the lead sponsor of 82 studies on the registry; 24 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 10 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients > 16 years.

Inclusion criteria

  • Subject undergoing a spine surgery with pedicle screw placement
  • Subject 16 years of age or older
  • Subject able to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Subject participating in a potentially confounding device or drug trial during the course of the study.
  • Subject meeting an exclusion criteria according to national law (e.g. pregnant woman, breast feeding woman)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
21 participants (actual)
Patient registry
No

Groups and cohorts

  • New image-guidance software

    Patients in this group had spine surgery with new image-guidance software application.

    Device: New image-guidance software

Interventions

  • DeviceNew image-guidance software

    Patients in this group had spine surgery with new image-guidance software application

06

What researchers measure

Primary outcomes

  1. Clinical Accuracy of Pedicle Screw Placement Using New Image-guidance Software

    Clinical accuracy of pedicle screw placements using new image-guidance software assessed by three independent reviewers. Accuracy grading was done per Gertzbein classification. Gertzbein classification: grade 0 = breach 0 mm, grade 1 = breach \< 2 mm, grade 2 = breach 2-4 mm, grade 3 = breach \> 4 mm. Values in the data table represent the percentage of screw placements that were determined accurate by three independent reviewers.

    Time frame: During surgery, mean 6.71 hours

Secondary outcomes

  1. Procedure Time

    Time from skin incision to skin closure

    Time frame: During surgery, mean 6.71 hours

  2. Time to Insert Pedicle Screw

    Time frame: Intraoperative, mean 5.18 hours

  3. Length of Hospitalization

    Time frame: From start of the interventional procedure until hospital discharge, approximately 5.3 days

  4. System Usability Score (SUS Score)

    The SUS is a validated standard questionnaire to evaluate the system usability. Score varies between 0 and 100 (0 meaning the lowest usability score, 100 meaning highest usability score).

    Time frame: End of all surgeries

  5. Patient Radiation Dose

    Radiation dose measured in Air Kerma (AK)

    Time frame: During surgery, mean 6.71 hours

  6. Patient Radiation Dose

    Radiation dose measured in Dose Area Product (DAP)

    Time frame: During surgery, mean 6.71 hours

  7. Radiation Dose (Effective Dose) Received by Operator

    Time frame: During surgery, mean 6.71 hours

  8. Procedure Related Complications

    Complication is leading to invasive intervention (e.g. blood sample, invasive intervention, IV/IM medication).

    Time frame: During surgery, mean 6.71 hours

  9. Adverse Events, Adverse Device Effects and Device Deficiencies That Could Have Led to a Serious Adverse Event

    Time frame: From start of enrollment until hospital discharge, approximately 51 days

07

Results

Posted Sep 30, 2019

Participant flow

Participant flow — Overall Study
MilestoneNew Image-guidance Software
Started21
Completed20
Not completed1

Outcome measures

PrimaryClinical Accuracy of Pedicle Screw Placement Using New Image-guidance Software

Clinical accuracy of pedicle screw placements using new image-guidance software assessed by three independent reviewers. Accuracy grading was done per Gertzbein classification. Gertzbein classification: grade 0 = breach 0 mm, grade 1 = breach \< 2 mm, grade 2 = breach 2-4 mm, grade 3 = breach \> 4 mm. Values in the data table represent the percentage of screw placements that were determined accurate by three independent reviewers.

Time frame:
During surgery, mean 6.71 hours
Reported as:
Number · Percentage of screw placements
Clinical Accuracy of Pedicle Screw Placement Using New Image-guidance Software
Percentage of screw placementsNew Image-guidance Software
Clinical Accuracy of Pedicle Screw Placement Using New Image-guidance Software94.1 (90.4 to 96.6)
SecondaryProcedure Time

Time from skin incision to skin closure

Time frame:
During surgery, mean 6.71 hours
Reported as:
Mean · Hours
Procedure Time
HoursNew Image-guidance Software
Procedure Time6.71 ± 1.69
SecondaryTime to Insert Pedicle Screw
Time frame:
Intraoperative, mean 5.18 hours
Reported as:
Mean · Minutes
Time to Insert Pedicle Screw
MinutesNew Image-guidance Software
Time to Insert Pedicle Screw5.18 ± 4.03
SecondaryLength of Hospitalization
Time frame:
From start of the interventional procedure until hospital discharge, approximately 5.3 days
Reported as:
Mean · Days
Length of Hospitalization
DaysNew Image-guidance Software
Length of Hospitalization5.3 ± 1.71
SecondarySystem Usability Score (SUS Score)

The SUS is a validated standard questionnaire to evaluate the system usability. Score varies between 0 and 100 (0 meaning the lowest usability score, 100 meaning highest usability score).

Time frame:
End of all surgeries
Reported as:
Mean · Scores on a scale
System Usability Score (SUS Score)
Scores on a scaleNew Image-guidance Software
System Usability Score (SUS Score)75.6 ± 13.9
SecondaryPatient Radiation Dose

Radiation dose measured in Air Kerma (AK)

Time frame:
During surgery, mean 6.71 hours
Reported as:
Mean · mGy (AK)
Patient Radiation Dose
mGy (AK)New Image-guidance Software
Patient Radiation Dose158.60 ± 71.014
SecondaryPatient Radiation Dose

Radiation dose measured in Dose Area Product (DAP)

Time frame:
During surgery, mean 6.71 hours
Reported as:
Mean · Gy.cm^2 (DAP)
Patient Radiation Dose
Gy.cm^2 (DAP)New Image-guidance Software
Patient Radiation Dose31.26 ± 12.604
SecondaryRadiation Dose (Effective Dose) Received by Operator
Time frame:
During surgery, mean 6.71 hours
Reported as:
Mean · μSv
Radiation Dose (Effective Dose) Received by Operator
μSvNew Image-guidance Software
Radiation Dose (Effective Dose) Received by Operator0.21 ± 0.261
SecondaryProcedure Related Complications

Complication is leading to invasive intervention (e.g. blood sample, invasive intervention, IV/IM medication).

Time frame:
During surgery, mean 6.71 hours
Reported as:
Number · Procedure related complications
Procedure Related Complications
Procedure related complicationsNew Image-guidance Software
Procedure Related Complications3
SecondaryAdverse Events, Adverse Device Effects and Device Deficiencies That Could Have Led to a Serious Adverse Event
Time frame:
From start of enrollment until hospital discharge, approximately 51 days
Reported as:
Number · Events
Adverse Events, Adverse Device Effects and Device Deficiencies That Could Have Led to a Serious Adverse Event
EventsNew Image-guidance Software
Adverse Events (serious and non-serious)5
Adverse Device Effects0
Device deficiencies that could have led to SAE0

Adverse events

Collected over From start of enrollment until hospital discharge, approximately 51 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
New Image-guidance Software0/20 (0%)1/20 (5%)4/20 (20%)
Most frequent serious events
Most frequent serious events
EventNew Image-guidance Software
Pain right leg due to foramina stenosis by L5 screw. Screw was placed by free-hand.Surgical and medical procedures1/20
Most frequent other events
Most frequent other events
EventNew Image-guidance Software
Horner's syndromeSurgical and medical procedures1/20
Postoperative painSurgical and medical procedures1/20
Repeated Xper-CTSurgical and medical procedures1/20
UrticariaSurgical and medical procedures1/20

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)New Image-guidance Software
<=18 years10
Between 18 and 65 years9
>=65 years2
Sex: Female, Male
Sex: Female, Male(Participants)New Image-guidance Software
Female12
Male9
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)New Image-guidance Software
Hispanic or Latino0
Not Hispanic or Latino0
Unknown or Not Reported21
Region of Enrollment
Region of Enrollment(participants)New Image-guidance Software
Sweden21
08

Study locations

1 site
  • Karolinska University Hospital
    Stockholm, Sweden
09

References and documents

Study documents

  • Study protocol · Oct 4, 2016
  • Statistical analysis plan · May 31, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03015142
Lead sponsor
Philips Clinical & Medical Affairs Global
Responsible party
Sponsor
First posted
Jan 9, 2017
Start date
Nov 9, 2016
Primary completion
Oct 8, 2017
Completion
Oct 8, 2017
Results posted
Sep 30, 2019
Last update
Mar 8, 2022

Study contacts

Adrian Elmi-Terander, MD
principal investigator · Karolinska University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion